Skip to main content
Top

Cellular Oncology

Issue 6/2016

Content (8 Articles)

Open Access Review

The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery

M. M. Hahn, R. M. de Voer, N. Hoogerbrugge, M. J. L. Ligtenberg, R. P. Kuiper, A. Geurts van Kessel

Original Paper

The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells

Ping Chen, Jian Li, Yong-Chang Chen, Hai Qian, Yu-Jiao Chen, Jin-Yu Su, Min Wu, Ting Lan

Original Paper

NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy

Vignesh Ramesh, Karthikeyan Selvarasu, Jaishree Pandian, Soundarajan Myilsamy, Chidambaranathan Shanmugasundaram, Kumaresan Ganesan

Open Access Original Paper

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study

F. J. Vogelaar, G. W. van Pelt, A. M. van Leeuwen, J. M. Willems, R. A. E. M. Tollenaar, G. J. Liefers, W. E. Mesker

Original Paper

DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up

Elisabetta Bigagli, Carlotta De Filippo, Cinzia Castagnini, Simona Toti, Francesco Acquadro, Francesco Giudici, Marilena Fazi, Piero Dolara, Luca Messerini, Francesco Tonelli, Cristina Luceri

Original Paper

Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis

Sweta Sharma Saha, Rahul Roy Chowdhury, Nidhu Ranjan Mondal, Biman Chakravarty, Tanmay Chatterjee, Sudipta Roy, Sharmila Sengupta

REPORT

WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report

Ilda Patrícia Ribeiro, Francisco Caramelo, Francisco Marques, Ana Domingues, Margarida Mesquita, Leonor Barroso, Hugo Prazeres, Maria José Julião, Isabel Poiares Baptista, Artur Ferreira, Joana Barbosa Melo, Isabel Marques Carreira

report

Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report

Xavier Tekpli, Vidar Skaug, Rita Bæra, David H. Phillips, Aage Haugen, Steen Mollerup

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine